Back to ARWR
Vestal Point Capital, LP → ARWR
Vestal Point Capital, LP ARWR Position History
Arrowhead Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$315.1M
Q3 2026
Peak value
$315.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $59.8M |
| Q1 2026 | $142.6M |
| Q2 2026 | $128.4M |
| Q3 2026 | $315.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $315.1M | 4.82M | — | — |
| Q2 2026 | $128.4M | 1.57M | — | — |
| Q1 2026 | $142.6M | 2.27M | — | — |
| Q4 2025 | $59.8M | 900.0K | — | — |
Other funds holding ARWR
$925.6M
$735.5M
$715.2M
$705.4M
$705.4M
$670.9M